Theravance Biopharma, Inc. (NASDAQ: TBPH) reported financial results for the second quarter 2014, and provided a corporate update. Revenue for the second quarter of 2014 was $3.0 million. Net loss for the second quarter of 2014 was $58.2 million or $1.83 per share. Cash, cash equivalents, and marketable securities totaled $387.4 million as of June 30, 2014. Theravance Biopharma, Inc. (NASDAQ:TBPH) belongs to Healthcare sector. Its weekly performance is -7.89%. On last trading day company shares ended up $27.44. Theravance Biopharma, Inc. (NASDAQ:TBPH) distance from 50-day simple moving average (SMA50) is -11.14%.

Investment analysts at Stifel Nicolaus began coverage on shares of Criteo SA (NASDAQ:CRTO) in a note issued to investors on Wednesday. The firm set a “hold” rating on the stock. Criteo SA (NASDAQ:CRTO) shares moved up 3.57% in last trading session and ended the day at $29.91. CRTO Gross Margin is 36.00% and its return on assets is 1.60%. Criteo SA (NASDAQ:CRTO) quarterly performance is -10.96%.

Majesco Entertainment Co. (NASDAQ:COOL) has announced thatCooking Mama 5: Bon Appétit will release on September 16, 2014 in North America. On 15 August, Majesco Entertainment Co. (NASDAQ:COOL) shares decreased -1.95% and was closed at $1.51. COOL EPS growth in last 5 year was -35.10%. Majesco Entertainment Co. (NASDAQ:COOL) year to date (YTD) performance is -63.44%.

Glimcher Realty Trust (NYSE:GRT) was downgraded by investment analysts at Raymond James from an “outperform” rating to a “market perform” rating in a note issued to investors on Monday. Glimcher Realty Trust (NYSE:GRT) ended the last trading day at $11.01. Company weekly volatility is calculated as 1.44%and price to cash ratio as 75.14. Glimcher Realty Trust (NYSE:GRT) showed a weekly performance of 2.71%.

GenCorp (NYSE:GY) VP Chris W. Conley unloaded 5,367 shares of the stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $18.34, for a total transaction of $98,430.78. Following the transaction, the vice president now directly owns 67,343 shares in the company, valued at approximately $1,235,071. The sale was disclosed in a filing with the SEC. GenCorp Inc. (NYSE:GY) shares remains unchanged in last trading session and ended the day on $18.52. GY Gross Margin is 11.00% and its return on assets is 8.00%. GenCorp Inc. (NYSE:GY) quarterly performance is 3.52%.